$1.03
N/A
Last update: Nov 5, 3:45 PM
Dogwood Therapeutics Inc
DWTXNASDAQ
The average analyst price target for Dogwood Therapeutics is $12, 1065.0% above the current price. The one analyst covering it rates it Buy. The latest change came on Sep 30, 2025, when HC Wainwright & Co. raised its price target on Dogwood Therapeutics from $10 to $12 and kept a Buy rating.
Price Target Range — 4 Quarters
Analyst Consensus — 1 Analysts
Rating Trend — Last 9 Months
